1. Home
  2. IPO
  • Chemkart India Ltd IPO
Chemkart India Ltd logo

Chemkart India IPO

  • Status: Closed
  • RHP:
  • ₹ 283,200 / 1200 shares

    Minimum Investment

Chemkart India IPO Details

  • Open Date

    07 Jul 2025

  • Close Date

    09 Jul 2025

  • Listing Date

    14 Jul 2025

  • IPO Price Range

    ₹ 236 to ₹248

  • IPO Size

    ₹ 75.96 Cr

  • Listing Exchange

    BSE SME

Open Free Demat Account

+91
Resend OTP

By proceeding, you agree to all T&C*

hero_form
Timeline Subscription Status Financials SWOT FAQ Contacts

Chemkart India IPO Timeline

Chemkart India IPO Subscription Status

Last Updated: 30 July 2025 11:26 AM by 5paisa

Chemkart India Limited is launching its IPO on July 7, 2025. Incorporated in 2015, the company specialises in distributing premium food and health ingredients, providing essential products to industries such as health supplements, sports nutrition, and herbal extracts.
The company operates a modern warehousing and processing facility spread over 28,259 sq. ft. in Bhiwandi, Mumbai, where grinding, blending, packaging, and labelling are carried out to meet high hygiene standards.

Established in: 2015
Managing Director: Mr. Ankit Shailesh Mehta
 

Chemkart India Objectives

The company intends to utilise the IPO proceeds for:

Funding Manufacturing Facility capex through wholly-owned subsidiary, Easy Raw Materials Pvt Ltd.
Repayment/prepayment of borrowings
General corporate purposes
 

Chemkart India IPO Size

Types Size
Total IPO Size ₹75.96 Cr
Offer For Sale ₹60.36 Cr
Fresh Issue ₹15.60 Cr

 

Chemkart India IPO Lot Size

Application Lots Shares Amount(₹)
Individual investors (Min) 2 1,200 2,83,200
Individual investors (Max) 3 1,200 2,83,200
S-HNI (Min) 3 1,800 4,24,800
S-HNI (Max) 6 3,600 8,49,600
B-HNI (Min) 7 4,200 9,91,200

Chemkart India IPO Reservation

Investors Category Subscription (times) Shares Offered Shares bid for Total Amount (Cr.)*
QIB 13.69 6,09,600 83,47,800 207.025
NII (HNI) 5.64 4,63,200 26,11,200 64.758
Individual Investors (IND category bidding for 2 Lots)     1.63 10,78,800 17,59,200 64.758
Total** 5.91 21,51,600 1,27,18,200 315.411

 

*The "Shares Offered" and "Total Amount" are calculated using the upper limit of the issue price range.
**Shares allocated to anchor investors (or market makers) are excluded from the total number of shares offered.

Profit and Loss

Balance Sheet

Particulars (in Rs. Crores) FY23 FY24 FY25
Revenue 131.69 132.83 205.46
EBITDA 7.66 14.52 24.26
PAT 11.05 20.91 32.76
Particulars (in Rs. Crores)] FY23 FY24 FY25
Total Assets 37.48 53.51 86.12
Share Capital 1.36 1.36 9.50
Total Borrowings 11.33 12.55 17.03
Particulars (in Rs. Crores FY23 FY24 FY25
Net Cash Generated From / (used in) operating activities 0.06 -0.02 3.97
Net Cash Generated From / (used in) investing activities -5.26 -0.19 -4.25
Net Cash Generated From / (used in) financing activities 5.33 0.15 3.05
Net Increase (Decrease) In Cash And Cash Equivalents 0.12 -0.06 2.76


Strengths

1. Diversified product portfolio catering to multiple industries
2. In-house processing and packaging facilities
3. Strong customer relationships and supply chain efficiency
4. Focus on the health and nutrition sector with growth potential
 

Weaknesses

1. A small workforce (40 employees) may limit rapid expansion
2. Operations are currently confined to India
3. Dependency on B2B customers may impact revenue stability
4. Profit margins can be affected by raw material price fluctuations
 

Opportunities

1. Growing demand for health and wellness products
2. Expansion potential into global markets
3. Rising popularity of sports nutrition and herbal products
4. Increasing B2B demand for reliable ingredient suppliers
 

Threats

1. Intense competition in the food and health ingredient sector
2. Volatility in raw material prices may impact costs
3. Regulatory challenges in the food and health product industries
4. Global supply chain disruptions can affect operations
 

1. Strong revenue and profit growth in recent years
2. Presence in the high-demand health and wellness sector
3. Experienced management and robust operations
4. Strategic use of IPO proceeds for working capital and expansion
 

1. The company operates in the fast-growing food and health ingredients distribution sector.
2. Rising demand for dietary supplements and wellness products boosts business prospects.
3. The Indian B2B ingredients market is expanding with increased focus on health and nutrition.
4. Chemkart benefits from global sourcing and efficient domestic supply chain capabilities.
5. Planned manufacturing expansion is expected to strengthen growth and market reach
 

Upcoming IPOs

View all IPOs
  • Companies
  • Type
  • Opening On

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91
Resend OTP

By proceeding, you agree to all T&C*

footer_form

FAQs

Chemkart India IPO opens on July 7, 2025 and closes on July 9, 2025.
 

Chemkart India IPO size is ₹75.96 Cr, comprising a fresh issue of ₹60.36 Cr and an offer for sale of ₹15.60 Cr.
 

Chemkart India IPO price band is ₹236 to ₹248 per share.

To apply for Chemkart India IPO, follow the steps given below:

  • Login to your 5paisa account and select the issue in the current IPO section
  • Enter the number of lots and the price at which you wish to apply for the Chemkart India IPO
  • Enter your UPI ID and click on submit. With this, your bid will be placed with the exchange

You will receive the mandate notification to block funds in your UPI app.
 

The minimum lot size of Chemkart India IPO is 1,200 shares with an investment of ₹2,83,200.
 

The tentative listing date of Chemkart India IPO is July 14, 2025, on the BSE SME platform.

Smart Horizon Capital Advisors Private Limited is the book-running lead manager of Chemkart India IPO.
 

Chemkart India will utilise proceeds for:

  • Funding Manufacturing Facility capex through wholly-owned subsidiary, Easy Raw Materials Pvt Ltd.
  • Repayment/prepayment of borrowings
  • General corporate purposes